Prevalence and characteristics of NTRK fusions in 25,946 patients with non-small cell lung cancer.

Saved in:
Bibliographic Details
Title: Prevalence and characteristics of NTRK fusions in 25,946 patients with non-small cell lung cancer.
Authors: Radonic T; Department of Pathology, Amsterdam University Medical Center & Cancer Center Amsterdam Amsterdam, Netherlands., Rahmani-Khajouei S; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland., Dafni U; ETOP Statistical Center, Frontier Science Foundation-Hellas & University of Athens, Athens, Greece., Stenzinger A; Department of Histopathology, University Hospital Heidelberg, Germany., Haberecker M; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland., Madsen LB; Department of Pathology, Aarhus University Hospital, Aarhus, Denmark., Monkhorst K; Division of Pathology, The Netherlands Cancer Institute, Amsterdam, Netherlands., Kowalski J; Department of Pathomorphology, Medical University of Gdansk, Gdansk, Poland., Hernandez-Losa J; Vall d'Hebron University Hospital, Barcelona, Spain., Kerr KM; Department of Pathology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom., Speel EJM; Department of Pathology, GROW-School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, Netherlands; Department of Pathology and Clinical Bioinformatics, Erasmus Medical Center, Rotterdam, Netherlands(1)., Bubendorf L; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland., Joseph L; Lung Cancer Group Manchester, Manchester, United Kingdom., Navarro A; Department of Pathology, Consorcio Hospital General Universitario de Valencia, Valencia, Spain., Thunnissen E; Department of Pathology, Amsterdam University Medical Center & Cancer Center Amsterdam Amsterdam, Netherlands., Sansano I; Vall d'Hebron University Hospital, Barcelona, Spain., Hillen LM; Department of Pathology, GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, the Netherlands., Biernat W; Department of Pathomorphology, Medical University of Gdansk, Gdansk, Poland., Christoffel M; Translational Research Coordination, ETOP IBCSG Partners Foundation, Bern, Switzerland., Tsamtsouri L; ETOP Statistical Center, Frontier Science Foundation-Hellas, Athens, Greece., Kammler R; Translational Research Coordination, ETOP IBCSG Partners Foundation, Bern, Switzerland., Peters S; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Zoche M; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland., Stahel RA; ETOP IBCSG Partners Foundation, Bern, Switzerland. Electronic address: rolf.stahel@etop.ibcsg.org., Finn SP; Department of Histopathology, St James's Hospital, Trinity College and Translational Medicine Institute, Dublin, Ireland.
Corporate Authors: ETOP Lungscape consortium
Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2026 Aug; Vol. 218, pp. 109514. Date of Electronic Publication: 2026 Jun 28.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1872-8332
DOI:10.1016/j.lungcan.2026.109514